EUVIMEDEUVIMED entdecken
Crossref

Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis

Yuko Asanuma iD, Kazuhisa Nozawa, Masakazu Matsushita, Makio Kusaoi, Yoshiyuki Abe, Ken Yamaji, Naoto Tamura

Modern Rheumatology · 2023

DOI: 10.1093/mr/roac143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Yuko Asanuma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Lupus Nephritis, Lupus Erythematosus, Systemic, Glomerulonephritis, Membranous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study was conducted to determine autoantibodies associated with lupus nephritis (LN), especially those useful in diagnosing proliferative and membranous nephritis.

Methods

A total of 106 patients with LN and 63 patients with systemic lupus erythematosus but no nephritis were enrolled; then, 55 patients were selected from the LN group and were divided into two groups: proliferative nephritis patients (n = 36) and membranous nephritis patients (n = 19). The autoantibody profiles of patients’ sera were evaluated using the EUROLINE ANA Profile 3 (IgG) kit.

Results

A higher positivity rate of anti-double-stranded DNA antibody and anti-histone antibody was seen in LN patients compared to nonrenal systemic lupus erythematosus patients. In comparing between proliferative and membranous nephritis, the positivity of anti-nucleosome antibody was higher in proliferative nephritis, although it was not statistically significant. However, anti-nucleosome antibody–positive patients with LN had a higher prevalence of haematuria and pyuria, which are strong indications of proliferative nephritis. Also, a significantly higher positivity rate of anti-RNP70 antibody was seen in membranous nephritis compared to proliferative nephritis.

Conclusions

Our results showed that anti-nucleosome and anti-RNP70 antibodies may be predictive nonhistological factors for discriminating between proliferative and membranous LN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisLupus Erythematosus, SystemicGlomerulonephritis, MembranousHumansAutoantibodiesNucleosomes

Stichwörter der Autor:innen

Anti-nucleosome antibodiesanti-RNP70 antibodiesautoantibodieslupus nephritissystemic lupus erythematosus

Substanzen

AutoantibodiesNucleosomes

Autor:innen und Institutionen

  • Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
  • Department of Internal Medicine and Rheumatology, Juntendo University Koshigaya Hospital, Saitama, Japan.

ORCID-Profile: Yuko Asanuma

Zitieren

APA

Asanuma, Y., Nozawa, K., Matsushita, M., Kusaoi, M., Abe, Y., Yamaji, K., & Tamura, N. (2023). Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis. Modern Rheumatology. https://doi.org/10.1093/mr/roac143

Vancouver

Asanuma Y, Nozawa K, Matsushita M, Kusaoi M, Abe Y, Yamaji K, et al. Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis. Modern Rheumatology. 2023. doi:10.1093/mr/roac143

BibTeX
@article{Asanuma2023,
  author = {Asanuma, Yuko and Nozawa, Kazuhisa and Matsushita, Masakazu and Kusaoi, Makio and Abe, Yoshiyuki and Yamaji, Ken and Tamura, Naoto},
  title = {Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis},
  journal = {Modern Rheumatology},
  year = {2023},
  doi = {10.1093/mr/roac143}
}
Kostenlos starten →